BF Biosciences Statistics

Total Valuation

BF Biosciences has a market cap or net worth of PKR 14.71 billion. The enterprise value is 14.72 billion.

Market Cap	14.71B
Enterprise Value	14.72B

Important Dates

The next estimated earnings date is Thursday, May 29, 2025.

Earnings Date	May 29, 2025
Ex-Dividend Date	n/a

Share Statistics

BF Biosciences has 88.33 million shares outstanding. The number of shares has increased by 8.15% in one year.

Current Share Class	n/a
Shares Outstanding	88.33M
Shares Change (YoY)	+8.15%
Shares Change (QoQ)	+16.66%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.01%
Float	25.00M

Valuation Ratios

The trailing PE ratio is 26.65.

PE Ratio	26.65
Forward PE	n/a
PS Ratio	2.52
PB Ratio	3.34
P/TBV Ratio	3.34
P/FCF Ratio	51.85
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.06, with an EV/FCF ratio of 51.87.

EV / Earnings	34.39
EV / Sales	3.26
EV / EBITDA	17.06
EV / EBIT	18.49
EV / FCF	51.87

Financial Position

The company has a current ratio of 2.06, with a Debt / Equity ratio of 0.47.

Current Ratio	2.06
Quick Ratio	1.19
Debt / Equity	0.47
Debt / EBITDA	2.41
Debt / FCF	7.33
Interest Coverage	51.22

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	12.40%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	195.01
200-Day Moving Average	n/a
Relative Strength Index (RSI)	39.12
Average Volume (20 Days)	1,195,880

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BF Biosciences had revenue of PKR 4.52 billion and earned 428.05 million in profits. Earnings per share was 6.25.

Revenue	4.52B
Gross Profit	2.01B
Operating Income	796.03M
Pretax Income	652.72M
Net Income	428.05M
EBITDA	862.89M
EBIT	796.03M
Earnings Per Share (EPS)	6.25

Full Income Statement

Balance Sheet

The company has 2.07 billion in cash and 2.08 billion in debt, giving a net cash position of -6.86 million or -0.08 per share.

Cash & Cash Equivalents	2.07B
Total Debt	2.08B
Net Cash	-6.86M
Net Cash Per Share	-0.08
Equity (Book Value)	4.41B
Book Value Per Share	49.93
Working Capital	2.09B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 556.54 million and capital expenditures -272.76 million, giving a free cash flow of 283.77 million.

Operating Cash Flow	556.54M
Capital Expenditures	-272.76M
Free Cash Flow	283.77M
FCF Per Share	3.21

Full Cash Flow Statement

Margins

Gross margin is 44.46%, with operating and profit margins of 17.61% and 9.47%.

Gross Margin	44.46%
Operating Margin	17.61%
Pretax Margin	14.44%
Profit Margin	9.47%
EBITDA Margin	19.09%
EBIT Margin	17.61%
FCF Margin	6.28%

Dividends & Yields

BF Biosciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.15%
Shareholder Yield	-8.15%
Earnings Yield	2.91%
FCF Yield	1.93%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BF Biosciences has an Altman Z-Score of 3.63.

Altman Z-Score	3.63
Piotroski F-Score	n/a